Update on the bifurcated EXCLUDER endoprosthesis: phase I results.
Many devices are being investigated for treatment of infrarenal abdominal aortic aneurysms. This report describes the particular characteristics of a next generation modular endograft and the Phase I results in 29 patients. Larger comparative studies are in progress to assess the safety and efficacy of this new design.
Matsumura
J S
JS
Northwestern University Medical School, Miami Cardiac & Vascular Institute, Mount Sinai School of Medicine, and Stanford University School of Medicine, USA.
Katzen
B T
BT
Hollier
L H
LH
Dake
M D
MD
D000368:Aged; D000369:Aged, 80 and over; D017130:Angioplasty / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods / Q000401:mortality; D017544:Aortic Aneurysm, Abdominal / Q000145:classification / Q000150:complications / Q000401:mortality / Q000601:surgery*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods / Q000401:mortality; D015897:Comorbidity; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011474:Prosthesis Design; D012720:Severity of Illness Index; D015607:Stents / Q000009:adverse effects / Q000592:standards; D016896:Treatment Outcome; D014654:Vascular Patency